Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOLOGIC NUF
NUF
Active
Org 994867725
Hausmanns Gate 6, 0186 Oslo
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2009
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 0
EBITDA margin
—
+4% vs 2022
Equity ratio
-89.9%
Financial strength
Net profit 2023
NOK -1,5M
-3253% vs 2022
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
NOK 0
—
EBITDA
NOK -16K
+4%
Net profit
NOK -1,5M
-3253%
Total assets
NOK 1,4M
-50%
Equity
NOK -1,2M
-478%
Employees
0
—
Company information
Legal name
BIOLOGIC NUF
Org number
994867725
Legal form
Norskregistrert Utenlandsk Foretak
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. desember 2009
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Company purpose
Utvikling av naturprodukter fra marin sektor.
Contact
Address
Hausmanns Gate 6, 0186 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2021
0M
2022
0M
2023
Income statement
NOK thousands
Item
2019
2020
2021
2022
2023
Revenue
0
0
18
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−17
−3
−428
−17
−16
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−17
−3
−428
−17
−16
Net financials
−35
−23
−12
−41
−1 470
Profit before tax
−52
−26
−440
−58
−1 487
Tax
−11
−6
−3
−13
35
Net profit
−41
−20
−438
−45
−1 522
Balance sheet
NOK thousands
Item
2019
2020
2021
2022
2023
Total assets
3 195
3 199
2 772
2 772
1 375
Equity
788
768
327
327
−1 237
Long-term debt
2 392
2 419
2 434
2 475
2 602
Short-term debt
16
12
11
26
11
Total debt
2 408
2 431
2 445
2 501
2 613
Financial ratios
5-year trend
EBITDA margin
-1641600.0%
This company
15.8%
Market median
-10389973% vs market
2019
2023
Equity ratio
-89.9%
This company
38.2%
Market median
-335% vs market
2019
2023
Return on equity
-152159900.0%
This company
18.4%
Market median
-826956078% vs market
2019
2023
Net profit margin
-152159900.0%
This company
8.1%
Market median
-1878517384% vs market
2019
2023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2023
Debt / equity
2.11×
This company
0.62×
Market median
-240% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AP
Arne Petter Holli
Chief Executive Officer
Chief Executive Officer
2009
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KL
Kristin Lowzow Holli
Chairman
2009
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
BIOLOGIC NUF
(this company)
MAX SIEVERT AS
MARINE INGREDIENTS SOLUTIONS AS
Board network connections
Board members of BIOLOGIC NUF also hold positions in
0
other companies.
Person
Role here
Other companies
Arne Petter Holli
Chief Executive Officer
0 companies
Kristin Lowzow Holli
Chairman
0 companies